Reports Q2 revenue $48.732M vs $43.554M last year. “Continuing our disciplined and strategic approach to investing through the first six months of 2025, we allocated capital toward growing Sila‘s portfolio of high quality, net-lease healthcare properties and purchasing outstanding shares at a price that we believe to be a significant discount to the intrinsic value of the Company,” stated Michael A. Seton, President and Chief Executive Officer of the Company.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.